- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05417412
Video-visit Behavior Therapy for Anxiety and Depression in Youth
May 7, 2024 updated by: V. Robin Weersing, San Diego State University
This project focuses on adapting and pilot testing an efficacious brief behavioral therapy (STEP-UP) for youths with anxiety or depression to be delivered as a telehealth intervention by clinic staff in low-resource community health centers (CHCs).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Kaiser Permanente Northwest Center for Health Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 17 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Youth is a patient at a participating community health center (CHC) site
- Youth is clinically referred by a provider and / or has anxiety and / or depression as a diagnosis or target problem in their medical record
- Youth is in the physical and legal custody of the caretaker and is not currently involved in the foster care system
- Youth is able and willing to conduct study assessments and intervention sessions in English
- Primary caretaker is able and willing to conduct study assessments and intervention sessions in English or in Spanish
- Youth is functioning at or above the academic level of a typical 8-year-old child (i.e., placed in at least the second-grade level school across all subjects in a general education classroom)
- Primary caretaker agrees that focusing on anxiety and / or depression would be a useful primary target for treatment
- Youth has clinically significant symptoms of anxiety and / or depression by youth or caretaker report
Exclusion Criteria:
- Youth is receiving an alternate intervention for anxiety or depression
- Youth or parent reports that the youth is experiencing active suicidal ideation with plan or intent (i.e., within last three months) and / or has made a suicide attempt within the last six months
- Youth or parent reports that the youth is currently engaging in non-suicidal self-injury (i.e., within last three months)
- Youth or parent reports that the youth has experienced recent physical or sexual abuse (i.e., within last three months).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: STEP-UP (brief behavioral therapy)
Intervention arm of open trial
|
8-12 sessions of brief behavioral therapy administered by behavioral health / mental health staff at participating community health centers (CHCs)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Minimum Attendance
Time Frame: Week 16 (post-intervention)
|
Receipt of a minimum dose of intervention.
A minimum dose was defined as 8 or more sessions of the intervention.
|
Week 16 (post-intervention)
|
|
Client Satisfaction Scale - Parent (CSQ-8-P)
Time Frame: Week 16 (post-intervention)
|
Parent ratings of satisfaction with the intervention.
Ratings of "mostly" or "very" satisfied were coded as "satisfied."
All other ratings were coded as "unsatisfied."
|
Week 16 (post-intervention)
|
|
Client Satisfaction Scale - Child (CSQ-8-C)
Time Frame: Week 16 (post-intervention)
|
Youth ratings of satisfaction with the intervention.
Ratings of "mostly" or "very" satisfied were coded as "satisfied."
All other ratings were coded as "unsatisfied."
|
Week 16 (post-intervention)
|
|
Participant Acceptability Questionnaire - Parent (PAQ-P)
Time Frame: Week 16 (post-intervention)
|
Parent ratings of the acceptability of the telehealth intervention.
Responses were classified as "little or no technical problems" or "technical difficulties."
|
Week 16 (post-intervention)
|
|
Participant Acceptability Questionnaire - Child (PAQ-C)
Time Frame: Week 16 (post-intervention)
|
Youth ratings of the acceptability of the intervention.
Youths were asked whether they would recommend the intervention to a friend.
Responses were included "would recommend" and "unlikely."
|
Week 16 (post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screen for Child Anxiety and Related Disorders - Parent (SCARED-P)
Time Frame: Week 16 (post-intervention)
|
Total score on the Screen for Anxiety and Related Disorders scale (parent report on youth), a dimensional measure of anxiety symptoms.
Scores range from 0 to 82, and higher scores indicate greater symptom severity.
Scores >= 25 may indicate the presence of an anxiety disorder.
|
Week 16 (post-intervention)
|
|
Screen for Child Anxiety and Related Disorders - Child (SCARED-C)
Time Frame: Week 16 (post-intervention)
|
Total score on the Screen for Anxiety and Related Disorders scale (youth report on self), a dimensional measure of anxiety symptoms.
Scores range from 0 to 82, and higher scores indicate greater symptom severity.
Scores >= 25 may indicate the presence of an anxiety disorder.
|
Week 16 (post-intervention)
|
|
Mood and Feelings Questionnaire - Parent (MFQ-P)
Time Frame: Week 16 (post-intervention)
|
Total score on the Mood and Feelings Questionnaire - parent report on youth (MFQ-P) a dimensional measure of depression symptoms.
Scores range from 0 to 68, and higher scores indicate greater depression symptom severity.
|
Week 16 (post-intervention)
|
|
Mood and Feelings Questionnaire - Child (MFQ-C)
Time Frame: Week 16 (post-intervention)
|
Total score on the Mood and Feelings Questionnaire (youth report on self) a dimensional measure of depression symptoms.
Higher scores indicate greater symptom severity.
Scores range from 0 to 66, and higher scores indicate greater depression symptom severity.
|
Week 16 (post-intervention)
|
|
Symptom Impairment Scale - Parent (SIS-P)
Time Frame: Week 16 (post-intervention)
|
Parent rating of child impairment in school, social, and family domains from symptoms of anxiety (3 questions) and depression (3 questions).
Higher scores indicate greater levels of perceived impairment.
Individual questions scores range from zero (not at all impairing) to three (very much impairing), and the total score ranges from 0 to 18.
|
Week 16 (post-intervention)
|
|
Symptom Impairment Scale - Child (SIS-C)
Time Frame: Week 16 (post-intervention)
|
Youth self-rating of impairment in school, social, and family domains from symptoms of anxiety (3 questions) and depression (3 questions).
Higher scores indicate greater levels of perceived impairment.
Individual questions scores range from zero (not at all impairing) to three (very much impairing), and the total score ranges from 0 to 18.
|
Week 16 (post-intervention)
|
|
Child Avoidance Measure - Parent (CAMP)
Time Frame: Week 16 (post-intervention)
|
Parent rating of youth avoidance behaviors due to anxiety.
Scores range from 0 to 24, and higher scores indicate greater avoidance.
|
Week 16 (post-intervention)
|
|
Child Avoidance Measure - Child (CAMP)
Time Frame: Week 16 (post-intervention)
|
Youth self-report rating of avoidance behaviors due to anxiety.
Scores range from 0 to 24, and higher scores indicate greater avoidance.
|
Week 16 (post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 2, 2021
Primary Completion (Actual)
August 30, 2022
Study Completion (Actual)
July 30, 2023
Study Registration Dates
First Submitted
June 9, 2022
First Submitted That Met QC Criteria
June 9, 2022
First Posted (Actual)
June 14, 2022
Study Record Updates
Last Update Posted (Actual)
May 16, 2024
Last Update Submitted That Met QC Criteria
May 7, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R56MH125159 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
NIH data archive as appropriate
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Brief Behavioral Therapy
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedDepression | Cancer | Anxiety | Unspecified Adult Solid Tumor, Protocol Specific | Cognitive Behavioral TherapyUnited States
-
The University of Texas Health Science Center at...59th Medical Wing; Brooke Army Medical Center; South Texas Veterans Health Care...CompletedCombat Disorders | Post-Traumatic Stress Disorders | Stress DisordersUnited States
-
Hospital General de MexicoEnrolling by invitationDepression | Anxiety | Sleep Quality | Insomnia Chronic | Life QualityMexico
-
Bath Spa University Academic Centre RAKCompletedDepression | Anxiety | Suicidal Ideation | Financial StressUnited Arab Emirates
-
Universidad de CórdobaUniversity Hospital Reina Sofia, Cordoba; State Research Agency, SpainNot yet recruitingGeneralized Anxiety Disorder | Anxiety | Somatoform Disorders | Generalized Anxiety | Emotional Disorders | Depression - Major Depressive Disorder | Somatization | Somatic Symptom Disorder (DSM-5)Spain
-
University of MinnesotaCompleted
-
Florida State UniversityRecruiting
-
Universidad Nacional Autonoma de HondurasUnknownAnxiety | Depressive Symptoms | Perceived Stress | Post Traumatic Stress SymptomsHonduras
-
Hartford HospitalOui Therapeutics, Inc.CompletedSuicidal and Self-injurious BehaviorUnited States
-
Universidad Santo Tomas, ChileUniversidad de ConcepcionCompletedDepressive Symptoms | Posttraumatic Stress Disorder | Acute Post-Traumatic Stress DisorderChile